Increased Cardiovascular Risks With Hydroxychloroquine vs Methotrexate in RA
Researchers evaluated the cardiovascular safety of hydroxychloroquine vs methotrexate among patients with rheumatoid arthritis.
All articles by Sheila Jacobs
Endobronchial Ultrasound-Guided TBNA Outcomes in Patients Aged 65 and Above
How do outcomes of endobronchial ultrasound-guided transbronchial fine needle aspiration differ in patients aged 65 or older vs those younger than 65?
Using Electronic Health Records to Predict Mortality Post COPD Hospitalization
For COPD, can electronic health record data predict 90-day post hospitalization mortality — and thereby serve as a risk stratification tool?
Red Blood Cell Distribution Width and Mortality in Patients With ARDS
Is red blood cell distribution width a predictor of outcomes in patients with acute respiratory distress syndrome who are critically ill?
Peanut Oral Immunotherapy in Children Evaluated via Real World Study
Is peanut oral immunotherapy well-tolerated by children in the real world, and does tolerance vary by age or by peanut protein dosage?
Omalizumab for Asthma in Children With High Pretreatment Serum IgE Levels
Is omalizumab beneficial for children with asthma whose pretreatment serum IgE levels are above the drug manufacturer’s age-approved therapeutic range?
Post-Hoc Analysis Reevaluates Effect of Lebrikizumab on Asthma Exacerbations
A post-hoc analysis of the LAVOLTA I and II trials assessed the effect of lebrikizumab on asthma exacerbations according to patients’ FeNO and eosinophil levels.
Mepolizumab Improves Loss of Smell in Chronic Rhinosinusitis With Nasal Polyps
The phase 3 SYNAPSE clinical trial evaluated the efficacy of mepolizumab in improving sense of smell in patients with chronic rhinosinusitis with nasal polyps.
Immunogenicity of COVID-19 Vaccines Among Immunocompromised Individuals
Do immunocompromised individuals produce antibodies after receipt of an RNA-based COVID-19 vaccination?
Managing Patients With COVID-19 and Common Variable Immunodeficiency
Are patients with common variable immunodeficiency at higher risk of adverse outcomes from COVID-19?
